University Hospital Essen at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University Hospital Essen takes part in 13 sessions at ESMO 2026 in Madrid. Its program centres on theranostics and radiopharmaceutical therapy, from how these drugs work to the patient experience and future development. Other sessions cover melanoma when neoadjuvant or adjuvant therapy fails, gastrointestinal stromal tumours, kidney and prostate cancer, and a PRAME-targeted T-cell engager for solid tumours.
| Organization | ESMO 2026 Attendance |
|---|---|
University Hospital Essen Essen, Germany | |
Teaching hospital of the University of Duisburg-Essen in Essen, Germany, with a comprehensive cancer centre. | Satellite Fri Oct 23 10:13–10:28 First-Line Patterns of Progression and Real-World Evidence Genitourinary cancers Talk Fri Oct 23 13:30–13:50 What works if neoadjuvant and adjuvant therapy doesn’t? Melanoma & skin cancers Chair Fri Oct 23 13:30–14:30 Abstract Fri Oct 23 16:15–16:25 Talk Fri Oct 23 16:15–16:35 See, target, treat: The power of theranostics Sarcoma, CNS, head & neck and rare cancers Satellite Fri Oct 23 18:20–19:00 Abstract Sat Oct 24 08:40–08:45 Chair Sat Oct 24 14:45–16:15 Proffered paper: Sarcoma Sarcoma, CNS, head & neck and rare cancers Keynote Sun Oct 25 12:20–12:45 Abstract Mon Oct 26 08:35–08:40 Talk Mon Oct 26 10:20–10:40 Image-guided strategy Genitourinary cancers Talk Mon Oct 26 15:25–15:45 The impact of new second lines: Leaving the comfort zone of fixed sequences Sarcoma, CNS, head & neck and rare cancers Satellite Mon Oct 26 18:30–20:00 Satellite Mon Oct 26 18:30–18:45 Satellite Mon Oct 26 18:45–19:15 Satellite Mon Oct 26 19:15–19:25 Satellite Mon Oct 26 19:25–19:40 Satellite Mon Oct 26 19:40–19:45 |
Instantly find 20 buyers from University Hospital Essen
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction